Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 14, 2021

SELL
$74.73 - $90.69 $7.54 Million - $9.15 Million
-100,844 Closed
0 $0
Q4 2020

Feb 16, 2021

SELL
$72.61 - $90.2 $6.82 Million - $8.47 Million
-93,900 Reduced 48.22%
100,844 $8.84 Million
Q3 2020

Nov 16, 2020

BUY
$71.87 - $131.03 $14 Million - $25.5 Million
194,744 New
194,744 $14.8 Million

Others Institutions Holding BMRN

About BIOMARIN PHARMACEUTICAL INC


  • Ticker BMRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 185,824,000
  • Market Cap $13.1B
  • Description
  • BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...
More about BMRN
Track This Portfolio

Track Sio Capital Management, LLC Portfolio

Follow Sio Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sio Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sio Capital Management, LLC with notifications on news.